Hamsoa Pharmaceutical
Central R&D Center

has been approved by the Korea Institute for Industrial Technology Promotion (KOTRA) in 2007. Since then, it has been carrying out various national and international research projects on various formulations and technology development projects.

We participated in the development of Korean traditional medicine technology development project with Korea Health Industry Development Institute and Korean Herbal medicine Foundation and developed capsular formulation of osteoarthritis treatment agent and asthma treatment agent for Knee joint. Through the Korea Oriental Industry Promotion agency and herbal medicine formulation modernization project, The formulation change to tablet or soft X-ray was successful.

Hamsoa Pharmaceutical's central Research Institute is trying to v and improve the convenience of taking them. Especially for pediatric patients who are not able to take tablets or capsules, they can reduce the bitterness of herbal medicine and liquid formulations. We are trying to develop drugs easily.

Hamsoa Pharmaceutical's central Research Institute is also developing the functional foods and general food products to enhance the convenience of taking pediatrics.
We are doing continuous research for gummy (bitter) mass kings, calcium liquid formulations, massaging, and improving the sweetness of lactic acid bacteria preparation. We strive to make it easier to access and take health-related functional products from children to adolescents.